Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2001-07-10
2004-12-14
Wax, Robert A. (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
06831151
ABSTRACT:
TECHNICAL FIELD
The present invention relates to a signal transducer specifically expressed in mouse and human mast cell, and polynucleotides (cDNAs) encoding this protein molecule. More particularly, the present invention relates to a novel protein that is useful, for example, as a target molecule far screening a therapeutic agent for allergic diseases, and various genetic engineering materials useful for production and functional analysis of this protein.
BACKGROUND ART
The type-I allergic response is a complicated immune reaction induced by release of granules containing histamine and serotonin through cross-linking of high affinity IgE receptors mainly expressed in the mast cell and basophilic leukocytes with IgE antibodies and allergens. This reaction has been elucidated to be composed of the following three stages:
A) An initial stage including production of cytokines such as IL-4 and IL-5 from T cell by stimulation of allergens, production of the IgE antibody from B cell, and differentiation and proliferation of the mast cells induced by production of the cytokines;
B) An intermediate stage from cross-linking of Fc&egr; receptors by the IgE antibody and allergen to degranulation of the mast cell; and
C) A later stage such as enhanced vascular permeability by histamine and serotonin after degranulation.
The inventors of the present invention have isolated an adapter molecule BASH that is specifically expressed in B cell (J. Immunol, 161:5804-5808, 1998). This BASH has a similar molecular structure to SLP-76 (J. Biol. Chem., 270:7029-7032, 1995) that is expressed in T cell, and indicates the presence of a family of signal transducers specific to hemopoietic immunoreceptors through structural and functional analysis.
While suppression of IgE antibody production (Primary Stage) by B cell using a hyposentitization therapy, or suppression of the later stage by administration of anti-histaminic agent have been used today for treating allergies, neither of them serves as an effective therapy in the current situations.
A part or the molecular mechanism of the type-I allergy response is being made clear, on the other hand, as described above. However, the signal transduction mechanism involved in degranulation of mast cell through the high affinity IgE receptor has not been known yet. It is inevitable to elucidate the molecule involved in the degranulation process of mast cell not only for elucidating the molecular mechanism of the allergy response but also for developing therapeutic methods or therapeutic agents of the allergic diseases. Particularly, since the mast cell plays a critical role in expression of the allergic conditions, the signal transducer that is specifically expressed in mast cell is quite important for developing novel antiallergic agents that selectively block the FC&egr; receptor signal transduction system that causes the degranulation reaction involving release of histamine and serotonin.
The object of the present invention performed based on the foregoing situations is to provide signal transducers specifically expressed in mouse and human mast cells, and polynucleotides (cDNAs) encoding these protein molecules.
Another object of the present invention is to provide various genetic engineering materials involved in the signal transducers.
DISCLOSURE OF INVENTION
For solving the problems above, the present invention provides the following inventions (1) to (10).
(1) A signal transducer specifically expressed in mouse mast cells, which is a purified protein having the amino acid sequence of SEQ ID No. 2.
(2) A signal transducer specifically expressed in human mast cells, which is a purified protein having the amino acid sequence of SEQ ID No. 4.
(3) A polynucleotide consisting of the base sequence of SEQ ID No. 1, which encodes the protein of (1).
(4) A polynucleotide having the base sequence of SEQ ID No. 3, which encodes the protein of (4).
(5) An expression vector involving the polynucleotide of (3).
(6) An expression vector involving the polynucleotide of (4).
(7) A cell transformed with the expression vector of (5), which produces the protein of (6).
(8). A cell transformed with the expression vector of (6), which produces the protein of (2).
(9) An antibody against the protein of (1).
(10) An antibody against the protein of (2).
REFERENCES:
Goitsuka et al. Int. Immunol. 12: 573-580 (2000).*
Cao et al., J. Exp. Med., vol. 190, No. 10, pp. 1527-1534 (1999).
Goitsuka et al., J. Immunol., vol. 161, pp. 5804-5808 (1998).
Jackman et al., J. Biol. Chem., vol. 270, No. 13, pp. 7029-7032 (1995).
Japan Science and Technology Corporation
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Mast cell-specific signal transducing molecules and cDNAs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mast cell-specific signal transducing molecules and cDNAs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mast cell-specific signal transducing molecules and cDNAs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3287108